# Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy

> **NCT00822029** · PHASE3 · TERMINATED · sponsor: **Department of Clinical Research and Innovation** · enrollment: 2 (actual)

## Conditions studied

- Osteoporosis
- Cerebral Palsy

## Interventions

- **DRUG:** FOSAMAX
- **OTHER:** PLACEBO

## Key facts

- **NCT ID:** NCT00822029
- **Lead sponsor:** Department of Clinical Research and Innovation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** only 2 patients inclued and Study Principal Investigator has left the hospital
- **Last updated:** 2012-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822029, "Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00822029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*